AP1S2 and cancer: Finally, similarly to that of AP1S2, the upregulation of AP1S3 was found to be linked with cancer cell aggressiveness among breast cancer patients and could be a target for small RNA silencing [59], which highlights its potential as a target for cancer treatment.